Furthermore, it was discovered before that BM-MSCs derived from relapsed/refractory patients with AML had lower expression levels of LYN and ITGB3 proteins, but higher expression levels of Gal-3 and p-CTNNB1 proteins [127]. Here, CTNNB1 is linked to acute myeloid leukemia.